Detalhe da pesquisa
1.
Patient reported experiences of Swedish patients being investigated for cancer during the Covid-19 pandemic.
Support Care Cancer
; 31(7): 416, 2023 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37354327
2.
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.
Br J Haematol
; 188(5): 685-691, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31612478
3.
Breast cancer survival trends in different stages and age groups - a population-based study 1989-2013.
Acta Oncol
; 58(1): 45-51, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30513223
4.
Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer.
Breast Cancer Res Treat
; 160(2): 313-322, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27722840
5.
Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer.
Clin Proteomics
; 12(1): 8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25878567
6.
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy.
Breast
; 71: 63-68, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37517154
7.
Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy.
J Clin Oncol
; 40(13): 1487-1496, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35077204
8.
Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen.
Breast Cancer Res Treat
; 126(2): 421-30, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20957430
9.
Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.
Radiology
; 260(3): 658-63, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21712474
10.
Low RAB6C expression is a predictor of tamoxifen benefit in estrogen receptor-positive/progesterone receptor-negative breast cancer.
Mol Clin Oncol
; 12(5): 415-420, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32257197
11.
RAB6C is an independent prognostic factor of estrogen receptor-positive/progesterone receptor-negative breast cancer.
Oncol Lett
; 19(1): 52-60, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31897114
12.
Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
Acta Oncol
; 48(4): 504-13, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19235568
13.
Three-dimensional reconstruction of seed implants by randomized rounding and visual evaluation.
Med Phys
; 34(3): 967-75, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17441243
14.
Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer.
Eur J Cancer
; 49(6): 1196-204, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23305873
15.
Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy.
Eur J Cancer
; 49(1): 115-20, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22951014
16.
Cyclooxygenase-2 expression in lung cancer cells evaluated by immunocytochemistry.
Diagn Cytopathol
; 39(3): 188-93, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21319320
17.
Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
J Thorac Oncol
; 4(3): 326-32, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19155996
18.
Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer.
J Natl Cancer Inst
; 101(5): 341-9, 2009 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-19244174